Regulators are increasingly leaning on the HBNR to crack down on the sharing of sensitive medical data, and the FTC seeks to strengthen its case.
Regulators are increasingly leaning on the HBNR to crack down on the sharing of sensitive medical data, and the FTC seeks to strengthen its case.